Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
By Staff Reporters
***
Microsoft: Microsoft Corp.’s stock dropped 2.6% on Wednesday to close at a seven-month low of $280.07. On Thursday, the software giant’s stock opened down 2.8% at $272.51, hit an intra-day low of $271.52, then bounced 8.5% off that low to close up 5.1% on the day at $294.59. The difference between Microsoft’s bullish engulfing and that of Twitter and Meta is that the downtrend has lasted only three months, since the stock closed at a record $343.11 on November. 19th. On Friday, the stock edged up 0.9% to $297.31.
Salesforce: Shares of Saleforce.com Inc. sank 2.4% on Wednesday to close at a 19-month low of $190.54, or 38.5% below its Nov. 8, 2021 record close of $309.96. Then on Thursday, it opened down 3.0% at $184.74, but bounced sharply to close up 7.2% at $204.29. The customer relationship management software company’s stock rose another 1.9% on Friday to $208.09, but remained the worst performer of the Dow Jones Industrial Average’s 30 components over the past three months with a loss of 26.8%.
AMAZON: The stock traded down roughly 9% across 2021and it’s down roughly 19% from the high that it hit last year. Lapping incredible, pandemic-driven performance, Amazon is facing some tough growth comparisons. Massive technology and infrastructure investments are also putting some pressure on earnings in the near term, but the business remains excellently positioned to win the future, and it will almost certainly be one of the most influential companies of the next decade [maybe]?
***
COMMENTS APPRECIATED
Thank You
Subscribe to the Medical Executive-Post
***
***
Share this:
Filed under: Alerts Sign-Up, Financial Planning, Investing | Tagged: Amazon, Investing, Meta, microsoft, Salesforce, stock markets, twitter | Leave a comment »
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 